* Cel-Sci Corp - a 1-for-25 reverse split was authorized for its outstanding shares of common stock Source text for Eikon: Further company coverage: Our Standards:The Thomson Reuters Trust Principles.
Reuters11mon
You can’t win with the tabloids. You’re either too fat, too thin, or hiding a deadly secret. This week’s tabloids continue their obsession with the stars’ weight, led by the ‘National Enquirer’ and its team of reporters expertly trained by ...
CEL-SCI Corporation (NYSE MKT: CVM) announced today that during its annual Shareholder’s Meeting on June 12, 2017, a 1-for-25 reverse split was authorized for its outstanding shares of common stock. CEL-SCI expects the split to be …
VIENNA, Va.--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE MKT:CVM) announced today that it has priced its public offering of common stock and warrants. CEL-SCI announced that it has agreed to sell 34,024,000 shares of common …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CVM at https://www.zacks.com/ap/CVM Keywords: Cel-Sci, Earnings Report
Moreover, the FDA approved Novartis’ Kymriah yesterday, making it the first CAR-T therapy to gain approval in the U.S. Kite already has a CAR-T therapy, axicabtagene ciloleucel (axi-cel), under priority ... year to date, the stock has gained …
HONG KONG, Mar 7, 2016 - (ACN Newswire) - China Everbright Limited ("CEL", stock code: 165.HK)'s Catalyst CEL Fund (the "Fund") is pleased to announce an investment into a disruptive 3D printing company XJet Ltd. ("XJet" or …